Overview
Morgan Alford practices practicing medicine in Vancouver, Canada.
Alford is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Pseudomonas Stutzeri Infections, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Cystic Fibrosis.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Morgan A. Alford
Is Morgan A. Alford a top-rated expert for Pseudomonas Stutzeri Infections?
MediFind is an objective health platform that identifies experts based on real-world data. Morgan A. Alford is classified as an Advanced expert for Pseudomonas Stutzeri Infections, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Morgan A. Alford participate in research or clinical trials?
Yes. Morgan A. Alford has published 21 articles and abstracts on conditions like Pseudomonas Stutzeri Infections. You can view a list of Morgan A. Alford's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pseudomonas Stutzeri Infections
- Experienced
- Cystic FibrosisAlford isExperienced. Learn about Cystic Fibrosis.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)